Botulinum toxin shows a notable capacity to reduce the prostate volume
Thursday, 9 April 2009 - Botulinum neurotoxin subtype A (BoNT-A) is the most powerful biological toxin known to man. Prof. Francisco Cruz, et al. reported on the notable capacity of BoNT-A to reduce the prostate volume. Such...
Correlation between OAB-Wet and serum adiponectin level, serum marker of metabolic syndrome
Monday, 6 April 2009- Obesity has increased dramatically, bringing major adverse consequences for human health. In particular, it is commonly accepted that metabolic syndrome results from obesity and obesity-linked insulin...
Cytokines in urine indicates urethral origin of urgency in OAB
Friday, 3 April 2009- The clinical observation of coexistence of urethral tenderness in the Overactive Bladder syndrome (OAB) raised interest for the hypothesis that urethra plays a role in OAB. Researchers in Sweden examined...
M2-receptor expression and lower urinary tract function
Wednesday, 1 April 2009- In vitro studies with bladder strips from several mammalian species including humans and in vivo studies with knock-out mice indicate that physiological bladder contraction is predominantly if not...




















